Remove market-access event
article thumbnail

The Pillars of Trust: Regulatory Compliance in Patient Engagement

PM360

Most marketers probably get more excited over the latest shiny new AI tool than a dusty old rule book. The Unique Challenges of Patient/Pharma Interaction Patient engagement has become a critical component of medical marketing. Patient marketers are educators and facilitators as much as they are brand champions.

article thumbnail

Pharma USA 2024 | March 26–27, 2024

Pharma Marketing Network

Pioneer healthcare’s transformation.   Healthcare reforms are finally paving the way to affordable access to medicines, yet this progress threatens the development of future life-saving therapies. The Register Now The post Pharma USA 2024 | March 26–27, 2024 appeared first on Pharma Marketing Network. Accelerate patient value.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PM360 Announces the Selections for its 12th Annual Innovations Issue

PM360

From developing ground-breaking new medicines to implementing better ways to ensure patients can access and stay on therapy to experimenting with new technology that changes how care is delivered—innovation is at the heart of everything this industry does. Register for the event at: [link].

article thumbnail

Reuters Pharma USA 2023 Recap

Pharma Marketing Network

Attending the Reuters Pharma Marketing 2023 event on March 28-29 was a fascinating experience as the pharma marketing industry continues to return to in-person events. The event included a focus on Medical Affairs, as a reflection of industry moving away from a ‘church and state’ approach to medical and commercial.

Pharma 52
article thumbnail

Informa Connect 2024 Events

Pharma Marketing Network

Upcoming Informa Connect Events: Speaker Programs Summit – February 26-28, 2024 Event Name: Rare Disease Summit – March 19-21, 2024 PAP – Patient Assistance & Access Programs – March 19-21, 2024 Hub and Specialty Pharmacy Models East – March 19-21, 2024 Pharma Forum – March 24-27, 2024 Pharmaceutical Compliance Congress (..)

article thumbnail

4D Molecular’s Fabry gene therapy program on FDA clinical hold

Pharmaceutical Technology

4D Molecular Therapeutics (4DMT), the California-based biotechnology company focused on developing gene therapies for rare and large market diseases, has had the FDA place a clinical hold onto its Fabry disease (FD) gene therapy program (4D-310).

FDA 105
article thumbnail

Next-gen Moderna COVID-19 vaccine shows promise

European Pharmaceutical Review

. “mRNA-1283 is a critical component of our combination vaccine against flu and COVID-19, mRNA-1083, and this milestone gives us confidence in our ability to bring this much needed vaccine to market.” 5 and original virus strains of SARS-CoV-2, compared to Moderna’s Spikevax vaccine.

Safety 97